Five new drugs given approval for use by Scottish NHS

Patients with thyroid cancer, Crohn’s disease and pneumonia will now be offered new treatments after new medicines were made available in ...

Read more →

Unique 'pay if you clear' proposal for new hepatitis drug

The NHS in Scotland could be reimbursed for the cost of a new hepatitis drug if sufferers fail to clear ...

Read more →

SMC advice - November 2013

[:content [\T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →

ABPI comments on Scottish New Medicines Fund

Commenting on the Scottish Government’s decision to establish a dedicated New Medicines Fund worth £40m, ABPI Scotland Director Andrew Powrie-Smith ...

Read more →

SMC - Forthcoming submissions

Below is a list of forthcoming submissions that have recently been added to the SMC's programme: ...

Read more →

Janssen statement: Update on the Scottish Medicines Consortium (SMC) decision on the use of Zytiga (abiraterone acetate) prior to chemotherapy

Following discussion with the Scottish Medicines Consortium (SMC) Janssen has requested that the SMC decision not to recommend the use ...

Read more →

Hepatitis C drug sofosbuvir approved for use on NHS

Experts have approved the use of a new drug to treat hepatitis C on the NHS. ...

Read more →

SMC - recently added forthcoming submissions

Below is a list of forthcoming submissions that have recently been added to the SMC's programme. ...

Read more →

Scotland doubles funding for access to new medicines

The Scottish government has announced a doubling of funding this year, from £20 million to £40 million, to improve patient ...

Read more →

SMC rejects Roche's Avastin for ovarian cancer, but six new drugs are in

Cost regulators for the National Health Service in Scotland have closed the door to Roche’s Avastin for ovarian cancer, but ...

Read more →

SMC advice - December 2013

[:content [\1 \1 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →

SMC OKs five new drugs for routine use in Scotland

Five new medicines have made it onto National Health Service treatment lists in Scotland for cancer, chronic obstructive pulmonary disease ...

Read more →

Scottish cost regulators OK NHS use of 7 new drugs

The Scottish Medicines Consortium has approved seven new medicines for use on NHS Scotland, including the first biologic treatment for ...

Read more →

Recently added forthcoming submissions - September 2014 update

Below is a list of forthcoming submissions that have recently been added to the SMS's work programme.   ...

Read more →

Scottish cancer sufferers denied life-saving drugs

Scottish patients with cancer are still facing a treatment lottery despite promises to increase access to life-extending drugs, campaigners have warned. ...

Read more →